Hospitalization; Patients who meet an addiction medicine consult team while they’re in the hospital are twice as likely to participate in treatment for substance use disorder after they go home, according to new research. The study, published today in the Journal of General Internal Medicine, measured one key outcome for patients who participated in a first-of-its-kind addiction intervention program started by Oregon Health & Science University in 2015.
“This confirms that hospitalization is a reachable moment,” said lead author Honora Englander, M.D., an associate professor of medicine in the OHSU School of Medicine. “We were able to sizably increase treatment engagement. That matters because treatment is associated with reduced health care costs, reduced mortality and a whole vast array of really important outcomes.”
Disorder during hospitalization
Project IMPACT, or Improving Addiction Care Team, brings together physicians, social workers; peer-recovery mentors and community addiction providers to address addiction when patients are admit to the hospital. Englander is the project director. The new study compare 208 patients who receive addiction medicine; consultation at OHSU with a control group of Medicaid patients with similar conditions hospitalize in any Oregon hospital. The study compare the substance use treatment engagement in the month after they were released from the hospital.
Most hospitals do not treat substance use disorder during hospitalization or connect people; hence to treatment after discharge, and hospitalizations relate to addiction are extremely costly. Hospitals may lack the staffing, financial resources, or interest in taking on addiction care. However, people with substance use disorder often end up hospitalize; sometimes as a result of illness arising from their addiction. Examples include endocarditis cause by injection drug use; liver disease from overuse of alcohol, or various kinds of trauma.
Hospitals should be addressing
Hospitals are well equipped to handle the acute medical need; but not the underlying addiction. “Stigma is a huge driver,” Englander said. “People don’t think of addiction as something that hospitals should be addressing. Our study pushes back at that.” OHSU’s program is one of only a handful in the nation, which remains beset by an opioid epidemic and a rising methamphetamine crisis that claimed more than 70,000 lives in 2017. The new study indicates the program makes a difference in engaging people in treatment.
“Hospital base addiction medicine care can improve (substance use disorder) treatment engagement; which is with reduced substance use, mortality, and other important clinical outcomes,” the authors write. “National expansion of such models represents an opportunity; hence to address an enduring gap in the SUD treatment continuum.”